Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $9.67 -0.79 (-7.55%) As of 04/3/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock Neoleukin Therapeutics Stock Price Performance 5 Day Performance-33.40%1 Month Performance-40.35%3 Month Performance-58.37%6 Month Performance-80.10%Year-To-Date Performance-57.90%1 Year Performance-77.32% Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address NLTX Stock Chart for Friday, April, 4, 2025 NLTX Chart by TradingViewRemove Ads Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$10.46$9.67-7.55%$10.54$9.37225,981 shs$90.88 million04/03/2025$9.66$10.46+8.34%$10.71$9.22391,066 shs$98.30 million04/02/2025$11.71$9.66-17.55%$11.99$9.59560,622 shs$90.74 million04/01/2025$14.52$11.71-19.35%$13.83$11.02678,766 shs$110.05 million03/31/2025$14.52$14.52$15.24$14.2498,621 shs$136.46 million03/28/2025$16.14$15.33-5.02%$16.64$14.81178,606 shs$144.07 million03/27/2025$13.96$16.14+15.62%$16.25$13.60219,404 shs$151.68 million03/26/2025$13.96$13.96$14.46$13.47240,117 shs$131.20 million03/25/2025$14.21$13.96-1.76%$14.46$13.47240,117 shs$131.20 million03/24/2025$14.21$14.21$15.23$13.81425,537 shs$133.55 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$15.42$15.23-1.23%$15.84$14.81138,319 shs$143.13 million03/20/2025$15.85$15.42-2.71%$16.34$15.16253,999 shs$144.92 million03/19/2025$16.87$15.85-6.05%$16.69$15.66310,629 shs$148.96 million03/18/2025$16.70$16.87+1.02%$17.38$16.41159,463 shs$158.54 million03/17/2025$16.70$16.70$17.24$16.46221,389 shs$156.95 million03/14/2025$17.78$16.80-5.51%$17.89$16.36147,380 shs$157.89 million03/13/2025$17.05$17.78+4.28%$18.62$17.45119,358 shs$167.10 million03/12/2025$17.05$17.05$17.40$16.65127,281 shs$160.24 million03/11/2025$17.28$17.05-1.33%$17.40$16.65127,281 shs$160.24 million03/10/2025$17.28$17.28$17.48$16.4476,721 shs$162.40 million03/07/2025$16.91$16.75-0.95%$16.99$16.24649,953 shs$157.42 million03/06/2025$16.35$16.91+3.43%$17.31$16.0888,912 shs$158.92 million03/05/2025$16.21$16.35+0.86%$16.51$15.69144,990 shs$153.66 million03/04/2025$17.69$16.21-8.37%$17.78$16.21170,058 shs$152.34 million03/03/2025$17.69$17.69$17.77$16.5459,469 shs$166.25 million Related Companies Valneva Stock Price Chart Immatics Stock Price Chart MeiraGTx Stock Price Chart Kura Oncology Stock Price Chart Opthea Stock Price Chart UroGen Pharma Stock Price Chart Sage Therapeutics Stock Price Chart Arvinas Stock Price Chart Maze Therapeutics Stock Price Chart PureTech Health Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
